Rabies Vaccine for Humans Market

The global Rabies Vaccine for Humans market was valued at US$ 1086.6 million in 2022 and is projected to reach US$ 1362.2 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Rabies Vaccine for Humans market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Rabies Vaccine for Humans market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Rabies Vaccine for Humans market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
Rabies Vaccine for Humans Market aims to provide a comprehensive presentation of the global market for Rabies Vaccine for Humans, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine for Humans. Rabies Vaccine for Humans Market contains market size and forecasts of Rabies Vaccine for Humans in global, including the following market information:
Global Rabies Vaccine for Humans Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rabies Vaccine for Humans Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Rabies Vaccine for Humans companies in 2022 (%)
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 71% of the share.
We surveyed the Rabies Vaccine for Humans manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Preventative Vaccine
• Emergency Rabies Vaccine

• Pre-exposure prophylaxis
• Post-exposure prophylaxis

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

• Key companies Rabies Vaccine for Humans revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Rabies Vaccine for Humans revenues share in global market, 2022 (%)
• Key companies Rabies Vaccine for Humans sales in global market, 2018-2023 (Estimated), (K Units)
• Key companies Rabies Vaccine for Humans sales share in global market, 2022 (%)

• Novartis
• Sanofi
• GlaxoSmithKline
• Merck
• Chengda
• Yisheng
• Prcmise
• VACN
• Changsheng
• BCHT
• Hissen

Chapter 1: Introduces the definition of Rabies Vaccine for Humans, market overview.
Chapter 2: Global Rabies Vaccine for Humans market size in revenue and volume.
Chapter 3: Detailed analysis of Rabies Vaccine for Humans manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rabies Vaccine for Humans in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rabies Vaccine for Humans capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

To know more about market statistics, Download a FREE Sample copy